These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7249570)

  • 41. [Type 2 diabetes: blood pressure lowering to 135/75 mmHg reduces mortality].
    Einecke D
    MMW Fortschr Med; 2007 Sep; 149(38):18. PubMed ID: 18018407
    [No Abstract]   [Full Text] [Related]  

  • 42. Possible induction of diabetes by treatment of hypertension with indapamide (with four case reports).
    Jian-Liang Z; Yong-Wen Q; Xing Z; Jian-Li Q; Jiang C; Rong-Liang X
    Diabetes Res Clin Pract; 2004 Sep; 65(3):243-6. PubMed ID: 15331204
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug corner. Atenolol (Tenormin).
    Roach AC
    Crit Care Nurse; 1982; 2(6):21-2. PubMed ID: 6924878
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical evaluation of a beta-blocking agent in a single daily dose].
    Di Veroli C; Compagno S
    Clin Ter; 1982 Jun; 101(6):623-8. PubMed ID: 6127182
    [No Abstract]   [Full Text] [Related]  

  • 45. [A prospective study of over 3,000 hypertensive patients shows: diuretic monotherapy decreases blood pressure significantly].
    Wagner K
    MMW Fortschr Med; 2000 Sep; 142(39):54. PubMed ID: 11072702
    [No Abstract]   [Full Text] [Related]  

  • 46. Experimental analysis of antihypertensive properties of S 5984 and its constituents: tertatolol and indapamide.
    Marmo E; Lampa E; Rosatti F; Berrino L; Russo S; Romano AR; Matera C
    Drugs Exp Clin Res; 1985; 11(10):709-15. PubMed ID: 2873980
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
    Bing RF; Russell GI; Swales JD; Thurston H
    Br J Clin Pharmacol; 1981 Dec; 12(6):883-6. PubMed ID: 7041937
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of indapamide 1.5 mg, sustained release, in the lowering of systolic blood pressure.
    London GM
    J Hum Hypertens; 2004 Dec; 18 Suppl 2():S9-S14. PubMed ID: 15592572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Very-low-dose combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide induces an early and sustained increase in neovascularization in rat ischemic legs.
    Silvestre JS; Kamsu-Kom N; Clergue M; Duriez M; Lévy BI
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1038-43. PubMed ID: 12438525
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Efficacy and safety of indapamide 1.5 mg sustained release coated tablets in the therapy of arterial hypertension].
    Asmar R
    Ann Cardiol Angeiol (Paris); 1998 Feb; 47(2):94-104. PubMed ID: 9772936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home.
    Hashimoto J; Hirayama H; Hanasawa T; Watabe D; Asayama K; Metoki H; Kikuya M; Ohkubo T; Totsune K; Imai Y
    Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Usefulness of atenolol in the ambulatory treatment of arterial hypertension].
    Demczuk M; Marszal-Marciniak M; Rafalska K; Krzemińska-Pakuła M
    Kardiol Pol; 1982; 25(7-8):533-9. PubMed ID: 6763100
    [No Abstract]   [Full Text] [Related]  

  • 54. [Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
    Greminger P; Vetter H; Boerlin HJ; Baumgart P; Havelka J; Walger P; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1982 Dec; 112(50):1831-5. PubMed ID: 7156966
    [No Abstract]   [Full Text] [Related]  

  • 55. [The use of acebutolol in arterial hypertension. Apropos of 13 records of Senegalese patients].
    Koate P; Diouf S; Sylla M; Sarr M
    Dakar Med; 1982; 27(4):547-64. PubMed ID: 7184740
    [No Abstract]   [Full Text] [Related]  

  • 56. [Newly diagnosed hypertensive. It calls for treatment immediately with a combination ].
    MMW Fortschr Med; 2003 Nov; 145(45):48. PubMed ID: 14712787
    [No Abstract]   [Full Text] [Related]  

  • 57. [Thermodiagnostic assessment of the trimepranol - prazosin combination in arterial hypertension (author's transl)].
    Kaderávek F
    Cas Lek Cesk; 1981 Jan; 120(2):47-51. PubMed ID: 6110481
    [No Abstract]   [Full Text] [Related]  

  • 58. [Treatment of arterial hypertension with orally administered atenolol].
    Sterkowicz W; Sterkowicz S
    Pol Tyg Lek; 1983 Feb; 38(8):238. PubMed ID: 6866841
    [No Abstract]   [Full Text] [Related]  

  • 59. [Alphamethyldopa vs. atenolol in the treatment of arterial hypertension].
    Magalhães LB; Guimarães AC
    Arq Bras Cardiol; 1986 Jun; 46(6):431-6. PubMed ID: 3555425
    [No Abstract]   [Full Text] [Related]  

  • 60. [The ORIGINAL program main results].
    Karpov IuA; Nedogoda SV; Kisliak OA; Deev AD;
    Kardiologiia; 2011; 51(3):36-41. PubMed ID: 21627611
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.